Eine Einrichtung der Stiftung der Cellitinnen e.V.
  • hidden image

Liste der
wissenschaftlichen Veröffentlichungen - 2017

Liste der
wissenschaftlichen Veröffentlichungen - 2017

Chip-based digital PCR as a novel detection method for quantifying microRNAs in acute myocardial infarction patients.
Robinson S, Follo M, Haenel D, Mauler M, Stallmann D, Heger LA, Helbing T, Duerschmied D, Peter K, Bode C, Ahrens I, Hortmann M.
Acta Pharmacol Sin. 2017 Nov 30. doi: 10.1038/aps.2017.136.
https://www.ncbi.nlm.nih.gov/pubmed/29188800

Circulating HtrA2 after primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: A potential novel biomarker for mitochondrial induced cardiomyocyte apoptosis and ischemia-reperfusion injury.
Hortmann M, Robinson S, Mohr M, Haenel D, Mauler M, Laumann R, Stallmann D, Reinoehl J, Duerschmied D, Peter K, Bode C, Ahrens I.
Int J Cardiol. 2017 Dec 15;249:437. doi: 10.1016/j.ijcard.2017.08.022.
https://www.ncbi.nlm.nih.gov/pubmed/29121749

Platelet-Targeted Delivery of Peripheral Blood Mononuclear Cells to the Ischemic Heart Restores Cardiac Function after Ischemia-Reperfusion Injury.
Ziegler M, Wang X, Lim B, Leitner E, Klingberg F, Ching V, Yao Y, Huang D, Gao XM, Kiriazis H, Du XJ, Haigh JJ, Bobik A, Hagemeyer CE, Ahrens I, Peter K.
Theranostics. 2017 Jul 22;7(13):3192-3206. doi: 10.7150/thno.19698.
https://www.ncbi.nlm.nih.gov/pubmed/28900504

Circulating HtrA2 as a novel biomarker for mitochondrial induced cardiomyocyte apoptosis and ischemia-reperfusion injury in ST-segment elevation myocardial infarction.
Hortmann M, Robinson S, Mohr M, Haenel D, Mauler M, Stallmann D, Reinoehl J, Duerschmied D, Peter K, Bode C, Ahrens I.
Int J Cardiol. 2017 May 24. pii: S0167-5273(16)34126-2. doi: 10.1016/j.ijcard.2017.05.088.
https://www.ncbi.nlm.nih.gov/pubmed/28602551

The mitochondria-targeting peptide elamipretide diminishes circulating HtrA2 in ST-segment elevation myocardial infarction.
Hortmann M, Robinson S, Mohr M, Mauler M, Stallmann D, Reinöhl J, Duerschmied D, Peter K, Carr J, Gibson CM, Bode C, Ahrens I.
Eur Heart J Acute Cardiovasc Care. 2017 May 1:2048872617710789. doi: 10.1177/2048872617710789.
https://www.ncbi.nlm.nih.gov/pubmed/28534645

Treatment and Secondary Prevention of Venous Thromboembolism - Change in Oral Anticoagulation
Helms TM, Gulba D, Ahrens I, Schäfer A, Hankowitz J, Kuhlencordt P, Lipp HP, Nikol S, Riess H, Stargardt T, Bramlage P.
Dtsch Med Wochenschr. 2017 Jul;142(13):986-993. doi: 10.1055/s-0042-124132.
https://www.ncbi.nlm.nih.gov/pubmed/28423431

Editor's Choice-The organization of chest pain units: Position statement of the Acute Cardiovascular Care Association.
Claeys MJ, Ahrens I, Sinnaeve P, Diletti R, Rossini R, Goldstein P, Czerwińska K, Bueno H, Lettino M, Münzel T, Zeymer U.
Eur Heart J Acute Cardiovasc Care. 2017 Apr;6(3):203-211. doi: 10.1177/2048872617695236.
https://www.ncbi.nlm.nih.gov/pubmed/28418691

Direct factor IXa inhibition with the RNA-aptamer pegnivacogin reduces platelet reactivity in vitro and residual platelet aggregation in patients with acute coronary syndromes.
Staudacher DL, Putz V, Heger L, Reinöhl J, Hortmann M, Zelenkofske SL, Becker RC, Rusconi CP, Bode C, Ahrens I.
Eur Heart J Acute Cardiovasc Care. 2017 Apr 1:2048872617703065. doi: 10.1177/2048872617703065.
https://www.ncbi.nlm.nih.gov/pubmed/28403626

Advocating cardiovascular precision medicine with P2Y12 receptor inhibitors.
Winter MP, Grove EL, De Caterina R, Gorog DA, Ahrens I, Geisler T, Gurbel PA, Tantry U, Navarese EP, Siller-Matula JM.
Eur Heart J Cardiovasc Pharmacother. 2017 Feb 15. doi: 10.1093/ehjcvp/pvw044.
https://www.ncbi.nlm.nih.gov/pubmed/28204303

Kontakt

Krankenhaus der Augustinerinnen
Klinik für Kardiologie und internistische Intensivmedizin
Jakobstraße 27 – 31
50678 Köln

Chefarzt:
Prof. Dr. med. Ingo Ahrens


Sekretariat:
Daniela Vanzetta
Lisa Bienengräber
Fon: 0221/3308-1851
Fax: 0221/3308-1852

Lage

Sie finden uns im
EG Kardiologie